We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Umbilical Cord Blood Test Can Detect Early Sepsis in Preterm Infants

By LabMedica International staff writers
Posted on 23 Jun 2025

Diagnosing early onset sepsis (EOS) in preterm infants is particularly difficult due to the lack of specific clinical signs, leading to widespread use of antibiotics while awaiting culture results. More...

Despite negative cultures, approximately 25% of very low birth weight newborns are continued on antibiotics under the presumption of infection. Now, researchers have identified specific proteins in umbilical cord blood that can signal systemic inflammation triggered by infection, offering a new, objective, and noninvasive method to diagnose EOS more accurately and reduce unnecessary antibiotic use.

The solution was developed by scientists from Ann & Robert H. Lurie Children's Hospital of Chicago (Chicago, IL, USA) who published their findings in JCI Insight. Their research focused on preterm newborns and aimed to identify reliable markers of EOS by examining umbilical cord blood collected at birth—a sample that provides a snapshot of the baby’s immune status at delivery. The method hinges on detecting specific proteins in the cord blood that reflect an acute immune response to infection. These biomarkers act as indicators of systemic inflammation, a key feature of EOS. In addition to identifying these proteins, the researchers also developed a machine learning-based diagnostic algorithm that integrates both biomarker data and known clinical risk factors to predict EOS with greater accuracy.

The study revealed that cord blood biomarker results can be processed and made available within 24 hours, allowing physicians to make more informed decisions early on. This timely information helps rule out sepsis confidently and discontinue antibiotics where unnecessary. Given that nearly 78% of very low birth weight infants currently receive antibiotics at birth, the new tool could significantly reduce unwarranted treatment and its associated risks. In practice, the approach offers several advantages. It provides an objective diagnostic aid in a condition often diagnosed based on suspicion alone, reduces prolonged antibiotic exposure, and ultimately lowers the risk of microbiome disruption, immune dysregulation, and other long-term health effects. By facilitating quicker and more precise diagnosis, the cord blood biomarker test and its associated algorithm may improve care standards for some of the most vulnerable newborns.

 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.